These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1147 related items for PubMed ID: 16195159

  • 1. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C, Rekvig OP, Nossent HC.
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [Abstract] [Full Text] [Related]

  • 2. [High titers of rheumatoid factor: clinical significance].
    Naranjo Hernández A, Rodríguez González T, Rodríguez-Lozano C, Ojeda Bruno S, Francisco Hernández F, Sánchez-García F, Bilbao Cantarero A.
    Rev Clin Esp; 1997 Apr; 197(4):232-6. PubMed ID: 9254397
    [Abstract] [Full Text] [Related]

  • 3. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC.
    Scand J Rheumatol; 2009 Apr; 38(4):240-5. PubMed ID: 19229766
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor.
    Spiritus T, Verschueren P, Westhovens R, Bossuyt X.
    Ann Rheum Dis; 2004 Sep; 63(9):1169-71. PubMed ID: 15308531
    [Abstract] [Full Text] [Related]

  • 5. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM, Mahmoud MH, El Mansoury TM, Osman AM.
    Scand J Rheumatol; 2008 Sep; 37(5):329-36. PubMed ID: 18666028
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [Abstract] [Full Text] [Related]

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 8. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H, McCarey D, Madhok R, Hampson R.
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [Abstract] [Full Text] [Related]

  • 9. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
    Le Loët X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, Pouplin S, Tron F, Zarnitsky C, Vittecoq O, Menard JF, Fardellone P.
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1739-47. PubMed ID: 20740612
    [Abstract] [Full Text] [Related]

  • 10. Performance of a rheumatoid arthritis records-based index of severity.
    Ting G, Schneeweiss S, Katz JN, Weinblatt ME, Cabral D, Scranton RE, Solomon DH.
    J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability].
    Aupperle KR, Alsalameh S, Stock KP, Burmester GR, Kalden JR.
    Z Rheumatol; 1996 Sep; 55(3):158-67. PubMed ID: 8768145
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
    Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME.
    J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
    [Abstract] [Full Text] [Related]

  • 13. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
    Saudan-Kister A, Gabay C, Tiercy JM, Mermillod B, Guerne PA, Vischer TL.
    Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
    [Abstract] [Full Text] [Related]

  • 14. [IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis].
    Naranjo Hernández A, Muniain Ezcurra MA, Vargas Lebrón MC, Rodríguez Barrera JM, Prieto Martínez J, Navarro Sarabia F.
    An Med Interna; 1989 Nov; 6(11):575-9. PubMed ID: 2562699
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE, Wiesner J, Bulpitt KJ, Patnaik M, Law J, Park GS, Wong WK.
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [Abstract] [Full Text] [Related]

  • 16. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ.
    Gerontology; 2009 Dec; 55(3):250-8. PubMed ID: 18849599
    [Abstract] [Full Text] [Related]

  • 17. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [Abstract] [Full Text] [Related]

  • 18. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Sihvonen S, Korpela M, Mustila A, Mustonen J.
    J Rheumatol; 2005 Nov; 32(11):2089-94. PubMed ID: 16265684
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Emery P.
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [Abstract] [Full Text] [Related]

  • 20. [Rheumatoid factors of immunoglobulin classes IgA, IgG and IgM: methods of determination and clinical value].
    Hermann E, Vogt P, Müller W.
    Schweiz Med Wochenschr; 1986 Sep 20; 116(38):1290-7. PubMed ID: 3775335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.